CD79A and cancer: Based on this we speculate that the use of IgA antibodies could unleash the cytotoxic potential of G-CSF mobilized immature neutrophils in antibody therapy of cancer that otherwise would be immunosuppressive, or even trigger re-polarization of PMN-MDSCs, due to FcαRI constitutive expression (128).